Anavex Life Sciences Corp. (NASDAQ: AVXL)
| Pre-Market |
Intra-Day |
After-Hours |
|
2.74
(0.04 /
1.48%)
|
2.75
(+0.05 /
+1.85%)
|
2.77
(+0.02 /
+0.73%)
|
| 31-Jul 08:05 |
31-Jul 16:00 |
31-Jul 17:43 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
2.70 |
Year Low |
2.26 |
| Open |
2.71 |
Year High |
11.70 |
| Day Low |
2.66 |
Price Avg 50 |
2.61 |
| Day High |
2.77 |
Price Avg 200 |
4.08 |
| Volume |
1.2 M |
Market Cap |
254.85 M |
News
Analysis
| AVXL |
1.85 |
10.89 |
6.18 |
-17.66 |
-41.49 |
-75.66 |
Earnings
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
EPS |
-0.11 |
-0.06 |
45.45 |
-0.14 |
57.10 |
|
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
REV |
|
|
0.00 |
|
0.00 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
EPS |
-0.15 |
-0.11 |
26.67 |
-0.14 |
21.40 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
REV |
|
|
|
|
|
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
EPS |
-0.14 |
-0.16 |
-14.29 |
-0.14 |
-14.30 |
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
REV |
|
|
0.00 |
|
0.00 |
|
Outlooks
* Growth at Outlook Mid-point against Estimate
Ratings
| 03/31/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/26/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/23/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 02/10/2026 |
AVXL |
HC Wainwright & Co. |
Buy |
Buy |
Maintain |
| 02/09/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 01/06/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars